Variant report

Variant	nsv526445
Chromosome Location	chr9:26239410-26248035
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:26237527..26239681-chr9:26241580..26243699,2	MCF-7	breast:
2	chr9:26237527..26239681-chr9:26241580..26243699,2	MCF-7	breast:

Extended variants
information (count: 426 )
Associated
traits (count: 116 )

Variant overlapped rSNPs/rCNVs (count:426 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs892688	chr9:26239410-26239411	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs189736822	chr9:26239427-26239428	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs182346472	chr9:26239484-26239485	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs371231697	chr9:26239509-26239510	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs374414266	chr9:26239510-26239511	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs538916240	chr9:26239554-26239555	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs557654451	chr9:26239557-26239558	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs187798922	chr9:26239559-26239560	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs536430005	chr9:26239561-26239562	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs528572935	chr9:26239669-26239670	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs191612500	chr9:26239693-26239694	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs572015177	chr9:26239709-26239710	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs573396424	chr9:26239714-26239715	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs534455306	chr9:26239728-26239729	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs552513587	chr9:26239740-26239741	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs577571965	chr9:26239831-26239832	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs183403533	chr9:26239835-26239836	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs561841706	chr9:26239838-26239839	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs144978390	chr9:26239905-26239906	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs147567965	chr9:26239910-26239911	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs115159901	chr9:26239917-26239918	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs542822924	chr9:26239939-26239940	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs142233644	chr9:26239950-26239951	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs528553962	chr9:26239996-26239997	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs547118088	chr9:26240000-26240001	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs565104833	chr9:26240004-26240005	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs372255514	chr9:26240029-26240030	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs532553453	chr9:26240036-26240037	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs188799573	chr9:26240043-26240044	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs375547050	chr9:26240065-26240066	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs569510763	chr9:26240074-26240075	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs536592020	chr9:26240100-26240101	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs548361789	chr9:26240103-26240104	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs529275689	chr9:26240108-26240109	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs566735227	chr9:26240154-26240155	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs550935914	chr9:26240163-26240164	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs144552320	chr9:26240165-26240166	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs193062880	chr9:26240169-26240170	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs145553610	chr9:26240194-26240195	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs184604722	chr9:26240224-26240225	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs187830299	chr9:26240240-26240241	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs191135475	chr9:26240243-26240244	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs530789226	chr9:26240256-26240257	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs183624464	chr9:26240265-26240266	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs561018308	chr9:26240273-26240274	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs552099435	chr9:26240295-26240296	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs570669423	chr9:26240343-26240344	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs368332324	chr9:26240403-26240404	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs573094769	chr9:26240418-26240419	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs540696135	chr9:26240471-26240472	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:116)

Disease	PMID	Source
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Cancer	22183965	CNVD
Acute myeloid leukemia	19651601	CNVD
Coronary Disease	20032323	CNVD
Squamous cell cancer	20885788	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21732550	CNVD
Gastric cancer	22539939	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Metastatic melanoma	18483359	CNVD
Non-small cell lung cancer	20864512	CNVD
Cervical cancer	21062161	CNVD
Acute myeloid leukemia	16864856	CNVD
Glioblastoma	17090523	CNVD
Lung cancer	16773561	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16774939	CNVD
Bladder cancer	19088036	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	16977458	CNVD
Glioblastoma multiforme	17369134	CNVD
Chagasic megaesophagus	20163722	CNVD
Melanoma	19566914	CNVD
Squamous cell cancer	19047905	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Hodgkin''s lymphoma	18179710	CNVD
Adenoid cystic carcinoma	18332873	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21858162	CNVD
Pancreatic cancer	21811587	CNVD
Barrett''s syndrome	19417022	CNVD
Myelofibrosis	22110671	CNVD
Urothelial cell carcinoma	18451213	CNVD
polycythaemia	22829968	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:28 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:26237800-26239800	Enhancers	HUVEC	blood vessel
2	chr9:26237800-26242800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
3	chr9:26239800-26242600	Weak transcription	HUVEC	blood vessel
4	chr9:26240000-26240200	Enhancers	Pancreatic Islets	Pancreatic Islet
5	chr9:26240400-26241600	Weak transcription	Pancreatic Islets	Pancreatic Islet
6	chr9:26240400-26249400	Enhancers	Hela-S3	cervix
7	chr9:26241600-26242200	Enhancers	Pancreatic Islets	Pancreatic Islet
8	chr9:26242200-26242600	Weak transcription	Pancreatic Islets	Pancreatic Islet
9	chr9:26242600-26245000	Enhancers	Pancreatic Islets	Pancreatic Islet
10	chr9:26242600-26245000	Enhancers	HUVEC	blood vessel
11	chr9:26242800-26245400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
12	chr9:26243200-26243800	Enhancers	NH-A	brain
13	chr9:26243200-26244400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr9:26243200-26244400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
15	chr9:26243200-26244800	Enhancers	Muscle Satellite Cultured Cells	--
16	chr9:26243200-26244800	Enhancers	A549	lung
17	chr9:26243200-26245800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr9:26243200-26248600	Enhancers	NHDF-Ad	bronchial
19	chr9:26243400-26245800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
20	chr9:26243800-26245600	Enhancers	Fetal Kidney	kidney
21	chr9:26244400-26245200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
22	chr9:26245200-26245400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr9:26245400-26247800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
24	chr9:26245800-26247400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
25	chr9:26245800-26248000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr9:26247400-26249000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
27	chr9:26247800-26248600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr9:26248000-26248600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links